0000947871-13-000521.txt : 20130717
0000947871-13-000521.hdr.sgml : 20130717
20130717192058
ACCESSION NUMBER: 0000947871-13-000521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130715
FILED AS OF DATE: 20130717
DATE AS OF CHANGE: 20130717
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WebMD Health Corp.
CENTRAL INDEX KEY: 0001326583
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 202783228
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 EIGHTH AVE.
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 212-624-3700
MAIL ADDRESS:
STREET 1: 111 EIGHTH AVE.
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER COMPANY:
FORMER CONFORMED NAME: WebMD Health Holdings, Inc.
DATE OF NAME CHANGE: 20050510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH JOSEPH E
CENTRAL INDEX KEY: 0001230617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35337
FILM NUMBER: 13973618
4
1
ss182033_4-smith.xml
OWNERSHIP DOCUMENT
X0306
4
2013-07-15
0
0001326583
WebMD Health Corp.
WBMD
0001230617
SMITH JOSEPH E
111 EIGHTH AVENUE
NEW YORK
NY
10011
1
0
0
0
Common Stock
2013-07-15
4
M
0
8888
20.23
A
48217
D
Common Stock
2013-07-15
4
M
0
8888
18.37
A
57105
D
Common Stock
2013-07-15
4
M
0
8888
19.04
A
65993
D
Common Stock
2013-07-15
4
S
0
26664
32.04
D
39329
D
Stock Option (Right to Buy)
20.23
2013-07-15
4
M
0
8888
0
D
2009-10-23
2014-01-01
Common Stock
8888
0
D
Stock Option (Right to Buy)
18.37
2013-07-15
4
M
0
8888
0
D
2009-10-23
2015-01-01
Common Stock
8888
0
D
Stock Option (Right to Buy)
19.04
2013-07-15
4
M
0
8888
0
D
2016-01-01
Common Stock
8888
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.04 to $32.06 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
25% of the shares underlying the option vested on the first anniversary of the grant date and 1/48 of the shares vested monthly thereafter over the next three-year period (fully vested on the 4th anniversary of the grant date). The date of grant for the option was ten years prior to the expiration date.
/s/ Lewis H. Leicher, Attorney-in-Fact for Joseph E. Smith
2013-07-17